DURECT Corporation (DRRX): Price and Financial Metrics

DRRX POWR Grades

• DRRX scores best on the Quality dimension, with a Quality rank ahead of 64.71% of US stocks.
• The strongest trend for DRRX is in Stability, which has been heading down over the past 177 days.
• DRRX ranks lowest in Stability; there it ranks in the 6th percentile.

DRRX Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for DRRX is 3.53 -- better than 85.15% of US stocks.
• Of note is the ratio of DURECT CORP's sales and general administrative expense to its total operating expenses; just 13.59% of US stocks have a lower such ratio.
• Revenue growth over the past 12 months for DURECT CORP comes in at 44.41%, a number that bests 87.54% of the US stocks we're tracking.
• Stocks that are quantitatively similar to DRRX, based on their financial statements, market capitalization, and price volatility, are BYSI, MEIP, PULM, EIGR, and BLPH.
• Visit DRRX's SEC page to see the company's official filings. To visit the company's web site, go to www.durect.com.

DRRX Valuation Summary

• In comparison to the median Healthcare stock, DRRX's price/earnings ratio is 107.49% lower, now standing at -2.
• DRRX's price/sales ratio has moved down 14.2 over the prior 243 months.

Below are key valuation metrics over time for DRRX.

DRRX Growth Metrics

Its 5 year net income to common stockholders growth rate is now at 32.71%.
• Its 4 year net cashflow from operations growth rate is now at 112.96%.
• The 2 year revenue growth rate now stands at -51.5%.

Over the past 49 months, DRRX's revenue has gone down $11,210,000.

The table below shows DRRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	23.265	-28.98	-31.872
2022-06-30	13.453	-34.11	-39.378
2022-03-31	13.68	-32.161	-36.973
2021-12-31	13.977	-37.311	-36.265
2021-09-30	5.489	-34.58	-24.897
2021-06-30	6.007	-35.905	-24.252

DRRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DRRX has a Quality Grade of C, ranking ahead of 38.99% of graded US stocks.
• DRRX's asset turnover comes in at 0.065 -- ranking 305th of 680 Pharmaceutical Products stocks.
• CCXI, LCI, and BHC are the stocks whose asset turnover ratios are most correlated with DRRX.

The table below shows DRRX's key quality metrics over time.